Actually, quite the opposite. Among other things, the ketone beta-hydroxybutyrate is a signalling metabolite that inhibits NLRP3 inflammatory activation, which inhibits cytokines production in chronic inflammation (so-called "angry inflammation"), which is a primary driving pathological process in cardiovascular disease.